Integrative Supportive Care Trial to Enhance physical Activity in Malignant pleural effusion (The Australasian Malignant PLeural Effusion (AMPLE)-5 Trial)

Not Applicable

Recruiting

• Conditions: Malignant pleural effusion; Cancer - Lung - Mesothelioma; Cancer - Other cancer types; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12624000038594
• Lead Sponsor: Institute of Respiratory Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-01-17
• Last Update Posted: 9 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1.Patients with previously confirmed MPE (histo-/cyto-logically confirmed OR recurrent large exudative pleural effusion with histo-cytologically proven cancer outside the thorax and no alternative cause)
2.Estimated survival of 3 months (the length of the supportive care intervention)

Exclusion Criteria

1.Age <18 years
2.Inability to consent
3.Inability to comply with protocol
4.Pregnancy/lactation
5.ECOG >3

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Physical activity level will be assessed as steps per day, measured by accelerometer (Sens Motion Activity Sensors) on their upper thigh.[ This will be a 7-day assessment of at baseline (enrolment) and a 7-day assessment of physical activity Post-intervention (week 13)]